Doç. Dr. Alper Azak
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Kidney Failure, Chronic 14 publicationsSource: OpenAlex / PubMed MeSHView publications
- Glomerulonephritis 6 publications
- Glomerulonephritis, IGA 6 publications
- Anemia 4 publications
- Proteinuria 4 publications
- COVID-19 4 publications
- Peritonitis 4 publications
- Coronary Artery Disease 3 publications
- Amyloidosis 3 publications
- Glomerulonephritis, Membranous 3 publications
- Glomerulosclerosis, Focal Segmental 3 publications
- Gram-Negative Bacterial Infections 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyNephrologysaglik.gov.trFrom source
- InstitutionBalıkesir Atatürk Şehir Hastanesisaglik.gov.trFrom source
- Area of workKidney Failure, ChronicExtracted from 14 publications · Model version —From source
- Publications100 publicationsORCID, OpenAlex, Europe PMCFrom source
- ORCID0000-0001-6228-8829ORCIDFrom source
- Last synchronised5 November 2026 07:37https://balikesirataturksehir.saglik.gov.tr/TR-677876/doktorlarimiz.html#alper-azaksaglik.gov.tr
Scientific work
Publications on Kidney Failure, Chronic
-
Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary Glomerulonephritis: A Nationwide Registry Analysis
Medicina, 2026
DOI 10.3390/medicina62050820 PMID 42195073 Open-access full textSource: ORCID
-
Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study
Clinical kidney journal, 2026
DOI 10.1093/ckj/sfaf120 PMID 41536569 1 citation (Europe PMC) Open-access full textSource: ORCID
-
Histopathological predictors of renal outcomes in idiopathic membranous nephropathy with a focus on global sclerotic glomeruli ratio
Scientific Reports, 2026
DOI 10.1038/s41598-026-61455-0 PMID 42706286 Open-access full textSource: OpenAlex
-
Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy
Scientific Reports, 2026
DOI 10.1038/s41598-025-33114-3 PMID 41501143 2 citations (Europe PMC) Open-access full textSource: ORCID
-
Sex Differences in Baseline Characteristics and Long-Term Outcomes of Primary Glomerular Diseases: Insights from the TSN-GOLD Registry
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15114017 PMID 42278877 Open-access full textSource: OpenAlex
-
Additional file 1 of Real-world epidemiology and renal outcomes of ADPKD in Türkiye: the PKD-TURK cohort
Figshare, 2026
DOI 10.6084/m9.figshare.34722363 Open-access full textSource: OpenAlex
-
Additional file 2 of Real-world epidemiology and renal outcomes of ADPKD in Türkiye: the PKD-TURK cohort
Figshare, 2026
DOI 10.6084/m9.figshare.34722366 Open-access full textSource: OpenAlex
-
Association Between SGLT2 Inhibitor Use and Post-Contrast Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Multicenter Cohort Study
medRxiv, 2026
DOI 10.64898/2026.02.20.26346726 Open-access full textSource: ORCID
-
Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15051850 PMID 41827265 Open-access full textSource: ORCID
-
Real-world epidemiology and renal outcomes of ADPKD in Türkiye: the PKD-TURK cohort
BMC nephrology, 2026
DOI 10.1186/s12882-026-05217-0 PMID 42902287 Open-access full textSource: Europe PMC